<html lang="en">
	<meta http-equiv='cache-control' content='no-cache'> 
	<meta http-equiv='expires' content='0'> 
	<meta http-equiv='pragma' content='no-cache'>
<head>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
	<title>MVT <i>in</i> Silico Corp., London Canada.</title>
	<link rel="stylesheet" href="styles.css">
</head>
<body>
	<center><img src="mvtISLogo_September2024.png" alt="MVTIS" witdth="100px"></center>
	<h1>MVT in Silico.</h1>
	<h2>Strap line</h2>
	We are MVT in Silico who apply the fundamental principles of life (biology, physics, quantum chemistry, math, 
	and computer science - in that order) to our clients products and build high specificity medical treatments.
	<h2>About Us.</h2>
	MVTIS is a life sciences software company that provides CM&S services for the life sciences. 
	We develop patent ready products and processes for our clients. We encompass a wide range of capabilities from 
	molecular drug-enzyme interactions to whole body circulation. Our product, a report consisting of
	validated recommendations, is designed to reduce the clientâ€™s R&D costs and form part of their regulatory evidence dossier.
	<h2> Challenge & our solution. </h2>
	<h2>Vision</h2>
	Derisk the process of critical illness drug and device development through a computer modelling & simulation (CM&S) first approach.
	To become a manufacturer of medical treatments in the mid term.
	<h2>Mission & Values</h2>
	MVTIS will use its life sciences computer modelling & simulation (CM&S) intellectual property (IP) to:
<li>	provide safe operating range estimates for client product;
<li>	work out failure modes of client product;
<li>	generating CM&S evidence to reduce time to patenting;
<li>	maintain and curate original data repositories for training future AI models;
<li>	develop their software as a medical device IP portfolio; and
<li>	combine the in house CM&S intellectual property, bioengineering/AI expertise, and unique position to develop two proprietary products within 7 years to become a manufacturer.
<li>	diversity and inclusion is at the core of our values.</li>
	<br>

	<h2>How it works.</h2>
	<li>Initial discussion.</li>
	<li>Business proposal by MVTIS, typically 14 month projects at a reasonable hourly FTE pricing.</li>
	<li>Client acceptance.</li>
	<li>Perform the CM&S, ditial twin testing of the system.</li>
	<li>Periodic reporting & agile management.</li>
	<li>Final report, IP, open articles, white papers.</li>
	<li>Develop and manufacture the physical product: devices, drugs, treatments.</li>
	<h2>Partners & Funders.</h2>
	<h2>Products & Pipelines.</h2>
	<h2>Projects</h2>
	<h2>Team</h2>
	<li>President, CEO, and Chief Science Officer. (founder)</li>
	<li>Pharmacology advisor.</li>
	<li>CFD advisor.</li>
	<li>Lawyer.</li>
	<h2>Contact</h2>
	<li>Phone: 5198780685 </li>
	<li>Email: sumus@mvtinsilico.ca </li>
	<li>Address: London, Ontario. </li>
	<li>LinkedIn:  </li>

	<h2>Terms of Use and Privacy Policy.</h2>

<p>Copyright. 2025. MVT in Silico Corp. All rights reserved.</p>
</body>
</html>